MDGL
Madrigal Pharmaceuticals Inc
$513.59
+0.02% (+$0.12)
Volume
210,723
52W High
$615.00
52W Low
$265.00
Market Cap
$11.58B
Next Earnings Report
Last Reported
May 12, 2026 Missed
Actual: -$1.38
vs. Consensus: -$0.89
Price Chart
EPS History: Consensus vs Actual
Last 11 quartersPrice Movement Around Earnings
Q1 2026
May 12, 2026
1-Day:
+1.69%
Q1 2026
May 6, 2026
1-Day:
-0.90%
5-Day:
-7.91%
Q1 2026
Apr 30, 2026
1-Day:
-0.71%
5-Day:
-2.88%
Q4 2025
Feb 19, 2026
1-Day:
-0.43%
5-Day:
+0.72%
Revenue & Financial Performance
| Quarter | Revenue | YoY Growth | Gross Margin | Op Margin | Net Income |
|---|---|---|---|---|---|
| Q4'25 | $321.1M | +210.8% | 92.4% | -18.6% | -$58.6M |
| Q3'25 | $287.3M | +362.0% | 93.7% | -39.7% | -$114.2M |
| Q2'25 | $212.8M | +1,353.8% | 95.7% | -22.2% | -$42.3M |
| Q1'25 | $137.3M | +10,000.0% | 96.7% | -57.8% | -$73.2M |
| Q4'24 | $103.3M | +10,000.0% | 96.7% | -64.8% | -$59.4M |
| Q3'24 | $62.2M | +10,000.0% | 96.5% | -187.1% | -$107.0M |
| Q2'24 | $14.6M | +5,261.9% | 95.7% | -1,110.4% | -$152.0M |
| Q4'23 | $770,000 | +670.0% | -18.4% | -10,000.0% | -$112.2M |
Company Information
Symbol
MDGL
Company
Madrigal Pharmaceuticals Inc
Market Cap
$11.58B